Difference between revisions of "Arentz M, et al, JAMA (2020), cited as Ref 11 in DOI:10.1007/s11886-020-01292-3 (Q10520)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Arentz M, #quickstatements; #temporary_batch_1592502690680) |
(Created claim: Second Author string (P150): Yim E, #quickstatements; #temporary_batch_1592502960189) |
||
| Property / Second Author string | |||
| + | Yim E | ||
| Property / Second Author string: Yim E / rank | |||
| + | Normal rank | ||
Revision as of 17:56, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Arentz M, et al, JAMA (2020), cited as Ref 11 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state (English)
0 references
Arentz M
0 references
Yim E
0 references
